Cerus CERS
NASDAQ CERS
$2.12 +0.17 (+8.72%)
At close: Nov 11, 2026 · 4:00 PM EST

Cerus (CERS) Cash from Restructuring (2009 - 2010)

Updated

Cerus (CERS) recorded Cash from Restructuring of -$113,000 in FY2010, compared with $113,000 in FY2009.

Analysis

Cerus (CERS) Cash from Restructuring (2009 - 2010) Analysis & Trends

  • Per Business Quant data, CERS's Cash from Restructuring was $113,000 in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Cerus 393.81 Mn 117.79 Mn 30.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2010 -24,000.00
Mar 31, 2010 -89,000.00
Dec 31, 2009 -96,000.00
Sep 30, 2009 -152,000.00
Jun 30, 2009 -291,000.00
Mar 31, 2009 652,000.00
API Access

Cerus Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=CERS&period=max&api_key=YOUR_API_KEY